Total Payments
$27,024
2024 Payments
$5,206
Companies
65
Transactions
1,363
Medicare Patients
2,837
Medicare Billing
$384,367
Payment Breakdown by Category
Food & Beverage$26,862 (99.4%)
Education$102.76 (0.4%)
Gifts$59.40 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,862 | 1,352 | 99.4% |
| Education | $102.76 | 10 | 0.4% |
| Gift | $59.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,762 | 155 | $0 (2024) |
| Abbott Laboratories | $2,577 | 73 | $0 (2024) |
| Amgen Inc. | $2,536 | 98 | $0 (2024) |
| Novo Nordisk Inc | $2,458 | 130 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,209 | 88 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,275 | 66 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,230 | 65 | $0 (2024) |
| Dexcom, Inc. | $1,143 | 98 | $0 (2024) |
| Mannkind Corporation | $938.23 | 59 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $848.26 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,206 | 223 | Abbott Laboratories ($916.96) |
| 2023 | $3,905 | 190 | Abbott Laboratories ($771.57) |
| 2022 | $3,634 | 175 | Abbott Laboratories ($572.76) |
| 2021 | $2,017 | 121 | Lilly USA, LLC ($244.58) |
| 2020 | $888.26 | 46 | Amgen Inc. ($198.94) |
| 2019 | $3,592 | 176 | Amgen Inc. ($520.63) |
| 2018 | $3,589 | 207 | AstraZeneca Pharmaceuticals LP ($666.80) |
| 2017 | $4,192 | 225 | AstraZeneca Pharmaceuticals LP ($785.09) |
All Payment Transactions
1,363 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: Endocrinology | ||||||
| 12/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Durable Pump | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Durable Pump | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Automated insulin delivery system | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 579 | 1,249 | $350,899 | $94,970 |
| 2022 | 5 | 1,058 | 2,201 | $374,973 | $102,468 |
| 2021 | 5 | 615 | 1,142 | $364,040 | $107,772 |
| 2020 | 6 | 585 | 999 | $326,675 | $79,157 |
Total Patients
2,837
Total Services
5,591
Medicare Billing
$384,367
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 411 | 893 | $294,879 | $81,390 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $30,060 | $7,360 | 24.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 75 | 178 | $19,402 | $4,799 | 24.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 88 | $4,488 | $922.40 | 20.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 21 | 30 | $2,070 | $498.37 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 448 | 960 | $317,730 | $87,550 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $26,553 | $6,522 | 24.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 70 | 158 | $17,222 | $4,323 | 25.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 464 | 1,000 | $11,398 | $3,537 | 31.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 30 | $2,070 | $535.40 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 460 | 957 | $316,348 | $94,846 | 30.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 70 | 70 | $35,070 | $9,533 | 27.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 43 | 70 | $7,576 | $1,993 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,838 | $893.40 | 31.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 30 | 32 | $2,208 | $506.25 | 22.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 418 | 802 | $265,713 | $63,986 | 24.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 55 | 55 | $27,305 | $6,724 | 24.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 47 | 55 | $18,781 | $4,719 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 23 | $5,221 | $1,338 | 25.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 26 | 45 | $4,905 | $1,288 | 26.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 18 | 19 | $4,750 | $1,102 | 23.2% |
About Dr. Omar Manlapaz, MD
Dr. Omar Manlapaz, MD is a Internal Medicine healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1730348426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Manlapaz, MD has received a total of $27,024 in payments from pharmaceutical and medical device companies, with $5,206 received in 2024. These payments were reported across 1,363 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($26,862).
As a Medicare-enrolled provider, Manlapaz has provided services to 2,837 Medicare beneficiaries, totaling 5,591 services with total Medicare billing of $384,367. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Duncanville, TX
- Active Since 06/06/2008
- Last Updated 04/28/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730348426
Products in Payments
- FREESTYLE LIBRE (Device) $2,261
- FARXIGA (Drug) $2,195
- JARDIANCE (Drug) $1,256
- Ozempic (Drug) $945.92
- AFREZZA (Drug) $938.23
- Repatha (Biological) $874.01
- Omnipod (Device) $829.02
- Korlym (Drug) $820.22
- MOUNJARO (Drug) $753.17
- TEPEZZA (Biological) $689.90
- Dexcom G6 Transmitter (Medical Supply) $613.13
- EVENITY (Biological) $554.59
- Vascepa (Drug) $480.06
- BAQSIMI (Drug) $479.14
- GVOKE PFS (Drug) $425.33
- V-GO (Device) $418.44
- GVOKE HYPOPEN (Drug) $398.12
- JANUVIA (Drug) $374.93
- Kerendia (Drug) $374.65
- HUMULIN (Drug) $355.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Duncanville
Dr. Ashwani Srivastava, M.d, M.D
Internal Medicine — Payments: $5,266
Internal Medicine $5,266
Dr. Dawn Gonzalez, Do, DO
Internal Medicine — Payments: $1,829
Internal Medicine $1,829
Mr. Alexander Peralta, Md, MD
Internal Medicine — Payments: $80.57
Internal Medicine $80.57
Fe Gonzaga, Md, MD
Internal Medicine
Internal Medicine